MedTrace Logo

Amyotrophic Lateral Sclerosis: A Multicenter Retrospective Observational Registry

NCT07143656 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2025-08-28

No results posted yet for this study

Summary

This retrospective observational study will analyze de-identified clinical data from patients with amyotrophic lateral sclerosis (ALS) collected at multiple centers over 7 years. The primary objective is to describe disease progression using the ALS Functional Rating Scale-Revised (ALSFRS-R). Secondary objectives include evaluating survival, ventilatory decline, and correlations between available biomarkers (e.g., neurofilament light chain, cytokines) and disease trajectory. No new interventions or patient contact will occur.

Conditions

  • Amyotrophic Lateral Sclerosis (ALS)
  • Amyotrophic Lateral Sclerosis &Amp; Other Neuromuscular Disorders

Interventions

BIOLOGICAL

Imaging and Clinical Reports

Inclusion of existing imaging data (MRI, EMG reports) and standard clinical documentation, where available.

Sponsors & Collaborators

  • Biocells Medical

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-13
Primary Completion
2028-08-13
Completion
2028-09-01
FDA Drug
Yes

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07143656 on ClinicalTrials.gov